Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

BESREMi is a preferred, FDA-approved option for both symptomatic low- and high-risk polycythemia vera patients. In the polycythemia vera space, BESREMi faces competition from drugs like ruxolitinib, a ...

Streaming Devices Market The streaming devices market grows with rising digital content demand, smart TV adoption, and advancements in wir ...

Autonomous Vehicle Market The autonomous vehicle market expands with AI, sensors, and connectivity, driving innovation, safety, and effici ...

Edgewell Personal Care Company (NYSE: NYSE:EPC), a global player in the personal care industry with annual revenue of $2.24 billion, has been facing a mix of challenges and opportunities as it ...

Cummins Inc . (NYSE:CMI), a global power leader in the U.S. Machinery & Construction sector, has been navigating a complex ...